Endpoints News 23. Feb. 2026 Novo Nordisk’s CagriSema beaten by Lilly’s Zepbound in head-to-head obesity trial
Endpoints News 22. Feb. 2026 MoonLake has 'confidence' ahead of FDA submission, discloses mid-stage arthritis win
Endpoints News 21. Feb. 2026 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more
Endpoints News 20. Feb. 2026 Supreme Court tariff ruling lets stand Trump’s authority to target pharma
Endpoints News 20. Feb. 2026 Novartis to divest India unit to private equity-led consortium for $159M
Endpoints News 19. Feb. 2026 Teva beats Corcept in appeals fight over generic Cushing's syndrome drug